A CRITIQUE OF CONTINUOUS INSULIN INFUSION PUMPS BY DIABETICS

InPharma ◽  
1981 ◽  
Vol 279 (1) ◽  
pp. 11-11
Keyword(s):  
Insulin Infusion ◽  
Infusion Pumps ◽  
Continuous Insulin Infusion

Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients

Diabetes ◽  
1985 ◽  
Vol 34 (11) ◽  
pp. 1127-1133 ◽  
Author(s):  
R. K. Mayfield ◽  
P. V. Halushka ◽  
H. J. Wohltmann ◽  
M. Lopes-Virella ◽  
J. K. Chambers ◽  
...  
Keyword(s):  
Platelet Function ◽  
Insulin Infusion ◽  
Diabetic Patients ◽  
Insulin Dependent ◽  
Insulin Dependent Diabetic ◽  
Continuous Insulin Infusion

Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs

Diabetes ◽  
1988 ◽  
Vol 37 (6) ◽  
pp. 749-759 ◽  
Author(s):  
R. T. Frizzell ◽  
G. K. Hendrick ◽  
D. W. Biggers ◽  
D. B. Lacy ◽  
D. P. Donahue ◽  
...  
Keyword(s):  
Insulin Infusion ◽  
Glucose Production ◽  
Conscious Dogs ◽  
Continuous Insulin Infusion

Insulin infusion pumps in pregnancy

2018 ◽  
pp. 368-372
Author(s):  
Ilana Jaye Halperin ◽  
Denice S. Feig
Keyword(s):  
Insulin Infusion ◽  
Infusion Pumps ◽  
In Pregnancy

Simplified Approach to Incorporating Glycemic Response Within a Continuous Insulin Infusion Algorithm to Improve the Incidence of Hypoglycemia in a Single Burn Center

2020 ◽  
Vol 41 (4) ◽  
pp. 791-795
Author(s):  
Hayden A Hendrix ◽  
Sai R Velamuri ◽  
Ibrahim Sultan-Ali ◽  
Faisal Arif ◽  
William L Hickerson ◽  
...  
Keyword(s):  
Insulin Infusion ◽  
Point Of Care ◽  
Glucose Monitoring ◽  
Burn Patients ◽  
Glycemic Response ◽  
Simplified Approach ◽  
Thermal Injuries ◽  
Continuous Insulin Infusion ◽  
Related Mortality

Abstract Attaining adequate glycemic control in burn patients has been shown to reduce infection-related mortality. Previous internal evaluation of continuous insulin infusion (CII) use revealed a hypoglycemia rate of 0.6% and an average time within goal glycemic range (70–149 mg/dl) of 13.8 h/day. A new algorithm, designed to adjust dosage based on glycemic response, underwent six iterations over 2 years before the final version was implemented. The purpose of this retrospective study was to assess the post-implementation performance of the newly developed CII algorithm. The current study was powered to detect a 50% reduction in hypoglycemic events, as compared to a pre-implementation historical control. The cohort was 62% male with a mean age of 54.5 ± 17.4. Sixty-five percent had thermal injuries with a median 23.5 (11–45) %TBSA. There were no differences in demographics between groups. Among the 20 records reviewed, 5239 point-of-care glucose values were assessed. Post-implementation, hypoglycemia rates were significantly lower (0.6% vs 0.2%; P < .001). There was no difference in median blood glucose between groups (149.9 vs 146.5 mg/dl; P = .56). Time spent within goal glycemic range was not significantly different (13.8 vs 14.7 h/day; P = 0.23). There were no differences in infection, length of stay, or survival. The consolidation, education, and implementation of a single, dynamic CII algorithm reduced the incidence of hypoglycemia. The authors expect that education and diligence with follow-up glucose monitoring will further improve time within goal glycemic range by preventing rebound hyperglycemia.

Sign in / Sign up

Export Citation Format

Share Document